课题基金 / 基金详情

The Botswana-Canada AIDS Vaccine Discovery Partnership

The Botswana-Canada AIDS Vaccine Discovery Partnership
博茨瓦纳-加拿大艾滋病疫苗发现伙伴关系
批准号：
234982
负责人：
Wainberg Mark A
金额：
$63.65万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-06-01 至 2014-06-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=234982&lang=en
关键词：
Hiv/Aids Neutralizing Antibody Vaccine

项目摘要

项目成果

Wainberg Mark A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The aim of our research is the discovery and characterization of highly potent broadly neutralizing antibodies that target HIV. We will use innovative immunologic techniques and cutting edge technologies to search for these rare antibodies in persons inf
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
What if HIV were unable to develop resistance against a new therapeutic agent?
Genetic signatures and functional phenotypes implicated in HIV-1 transmission and drug resistance
The Botswana-Canada AIDS Vaccine Discovery Partnership
The Impact of HIV Drug Resistance Mutations in Different Viral Subtypes on Viral Fitness and Phenotype
海外基金